The coming of age story of RNAi technology
The first RNA interference (RNAi) therapy was approved in 2018, after 20 years in development.…
July 22, 2022 - 7 minutes
Silence Therapeutics
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
December 28, 2020 - 12 minutes
Silence Therapeutics to Work with AstraZeneca in RNAi Deal Worth up to €3.6B
AstraZeneca is recruiting RNAi specialist Silence Therapeutics to develop treatments for cardiovascular, renal, metabolic, and…
March 26, 2020 - 3 minutes
Mallinckrodt Teams up with UK RNAi Biotech in Deal Worth up to €553M
The UK-based biotech Silence Therapeutics has signed a deal worth up to €553M ($693M) with…
July 19, 2019 - 2 minutes
UK Biotech Settles Lawsuit on the First RNAi Drug
Silence Therapeutics and Alnylam have reached a settlement that puts an end to a legal…
December 11, 2018 - 3 minutes
Walking with the Dinosaurs of European Biotech: Which of Them is Roaring the Loudest?
Although biotech may seem like an industry that has only just gotten started, it was…
January 23, 2018 - 10 minutes
RNA as a Therapy: Reviewing the Future Generation of Therapeutics
You’ve certainly heard about antibodies, peptides and even DNA as therapeutics, but what about RNA?…
September 19, 2017 - 9 minutes
CRISPR meets RNAi: a whole new Targeted Therapy
Silence Therapeutics just announced preclinical data for a novel CRISPR therapy targeted to the liver using…
November 15, 2016 - 2 minutes
